Christi Jen, Pharm D, BCPSEmergency Medicine Clinical Pharmacist PGY1 Residency Program Director Banner Boswell Medical Center Sun City, Arizona Delia Saadeh, Pharm D Candidate 2016Sabrina La Spisa, Pharm D Candidate 2016Thuy Linh Nguyen, Pharm D Candidate 2016Laura V. Tsu, Pharm D, BCPS, CGPAssistant Professor of Pharmacy Practice Midwestern University College of Pharmacy–Glendale Glendale, Arizona US Pharm. ABSTRACT: Rates of pertussis (whooping cough) in adolescents and adults have been steadily increasing in the United States. Owing to the atypical presentation of symptoms in this population, proper prevention and treatment are particularly important to reduce the risk of transmission to young children and infants. Treatment of pertussis involves the use of antimicrobial therapy, particularly macrolide antibiotics. Infection prevention in adults is managed through scheduled vaccination with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap). Pharmacists are accessible sources of immunization education and administration, and they can impact infection outcome in patients through timely referrals for antimicrobial treatment and education regarding treatment options and expected outcomes. Pertussis, an acute respiratory infection caused by Bordetella pertussis, is characterized by a paroxysmal cough lasting ≥2 weeks, an inspiratory whoop, posttussive emesis, and posttussive syncope. Of whooping cough is using antibiotics and "palliative" care. They know that..., I know that..., but they won't tell you that, for the simple reason that... When you walk into your doctor's office, the first thing they do- Both of which are untrue, but who's going to doubt the word of the doctor, other than those of us, who have been there done that, and proven them wrong? The second thing some parents experience, is being told that... While the medical profession talks about antibiotics making the infection less severe if you catch it very early, the real world reality is that because most of the carriers of whooping cough don't know they have it, most often parents don't know their children have it until about six week month AFTER they first contacted it: Whooping cough is spread by carriers. The real world reality, is that most of the carriers of whooping cough don't know they have it; most are asymptomatic (no symptoms) and most often parents don't know their children have it until about four to six weeks AFTER they first contacted it: Looking at the time frames, incubation is listed as 5 - 15 days . This is followed by an insignificant cold which lasts about a week, then goes away = 12 - 22 days. After about a one week pause, = 19 - 31 days, the cough starts. Most parents don't get concerned until about two weks into the cough, when it's getting worse, and NOT going away. So usually a parent doesn't usually get the child to the doctor until around 33 - 45 days after initial contact. If the mantra is that antibiotics only "work" to reduce severity within 3 weeks of contact, what parent is actually going to make it to the doctor in that time frame?
Pertussis or whooping cough is typically characterised by paroxysms of coughing with a whooping sound during inhalation. Whooping cough is caused by Bordetella pertussis and is highly contagious. Although childhood immunisation has been effective in preventing the disease, outbreaks in Australia have been associated with waning immunity in older children and adolescents. The peak incidence of infection now occurs in people aged 15 or older. When given early in the illness, antibiotics can decrease the infectious period, but have no effect on the duration or severity of disease. Symptomatic treatment of cough has shown no clear benefit. Antibiotic prophylaxis of contacts is recommended for certain high-risk groups, but there is limited evidence of its effectiveness. Although infants remain the most at risk for severe, life-threatening disease, it is adolescent and adult booster immunisation which remains critical for prevention programs. Pertussis has significantly increased in Australia, particularly in older children and adults. These patients do not always exhibit classical symptoms and are an important source of infection for young infants. Antibiotic treatment, isolation of index cases and timely vaccination are important strategies to prevent transmission of pertussis. Evidence of the efficacy of chemoprophylaxis for pertussis is limited. Assessing efficacy is often confounded by a delay in diagnosis of the index case. Antibiotic prophylaxis after exposure to pertussis aims to limit transmission to non-immune contacts. It is recommended for high-risk groups such as unimmunised infants, women in late pregnancy and individuals who may be a source of infection.
Whooping cough also known as pertussis or 100-day cough is a highly contagious bacterial disease. Initially, symptoms are usually similar to those of the common. Establishes the medication azithromycin Zithromax, Zithromax Tri-Pak, Zithromax Z-Pak, Zmax, a drug that is effective against susceptible bacteria causing.